Budesonide orodispersible tablets are superior to maintain combined clinical and histological remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Alex Straumann  ¹     Alfredo J. Lucendo  ²     Stephan Miehlke  ³     Michael Vieth  ⁴     Christoph Schlag  ⁵     Luc Biedermann  ⁶     Cecilio Santander Vaquero     Constanza Ciriza De Los Ríos     Dirk Hartmann     Ahmed Madisch     Petr Hruz     Jamal Hayat     Ulrike von Arnim     Arjan Bredenoord     Stefan Schubert     Ralph Müller     Roland Greinwald     Alain Schoepfer     Stephen     
¹ Swiss EoE Research Network,Olten,Switzerland
² Hospital General de Tomelloso Dept. of Digestive Health,Tomelloso,Spain
³ Coopertion of Internal Medicine Center for Digestive Diseases,Hamburg,Germany
⁴ Klinikum Bayreuth Abt. Pathology,Bayreuth,Germany
⁵ Technische Universität München,München,Germany
⁶ USZ Z&uu

Session
What's hot in eosinophilic oesophagitis (Posters)

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019